(Q37808469)

23 August 2017

title

Mixed bacterial-fungal infections in the CF respiratory tract (English)

1 reference

23 August 2017

2

0 references

author name string

Laurie Whittaker Leclair

series ordinal

1

1 reference

23 August 2017

publication date

1 November 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

48 Suppl 1

1 reference

23 August 2017

page(s)

S125-32

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

23 August 2017

1 reference

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Cystic fibrosis since 1938.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Development of an oligonucleotide array for direct detection of fungi in sputum samples from patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF. European Epidemiologic Registry of Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Case-control study of Stenotrophomonas maltophilia acquisition in cystic fibrosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

IL-23 mediates inflammatory responses to mucoid Pseudomonas aeruginosa lung infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

An integrated model of the recognition of Candida albicans by the innate immune system.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Th2 allergic immune response to inhaled fungal antigens is modulated by TLR-4-independent bacterial products

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Reduced IL-10 secretion by CD4+ T lymphocytes expressing mutant cystic fibrosis transmembrane conductance regulator (CFTR).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Partial correction of the CFTR-dependent ABPA mouse model with recombinant adeno-associated virus gene transfer of truncated CFTR gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Oral colonization by Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Implications of endotracheal tube biofilm for ventilator-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Pseudomonas-Candida interactions: an ecological role for virulence factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

A novel DSF-like signal from Burkholderia cenocepacia interferes with Candida albicans morphological transition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Early anti-pseudomonal acquisition in young patients with cystic fibrosis: rationale and design of the EPIC clinical trial and observational study'

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Biofilms: survival mechanisms of clinically relevant microorganisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Mechanisms of biofilm resistance to antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Candida albicans and Staphylococcus aureus form polymicrobial biofilms: effects on antimicrobial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

The role of pyocyanin in Pseudomonas aeruginosa infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Pseudomonas aeruginosa-Candida albicans interactions: localization and fungal toxicity of a phenazine derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Signal-mediated interactions between Pseudomonas aeruginosa and Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Multiple homologues of LuxR and LuxI control expression of virulence determinants and secondary metabolites through quorum sensing in Pseudomonas aeruginosa PAO1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Structure of the autoinducer required for expression of Pseudomonas aeruginosa virulence genes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Pseudomonas aeruginosa quorum-sensing systems may control virulence factor expression in the lungs of patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

A Pseudomonas aeruginosa quorum-sensing molecule influences Candida albicans morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Farnesol and dodecanol effects on the Candida albicans Ras1-cAMP signalling pathway and the regulation of morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Farnesol induces hydrogen peroxide resistance in Candida albicans yeast by inhibiting the Ras-cyclic AMP signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Pseudomonas aeruginosa pyocyanin and 1-hydroxyphenazine inhibit fungal growth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Development of selective media for the isolation of yeasts and filamentous fungi from the sputum of adult patients with cystic fibrosis (CF).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Evaluation of Pyrosequencing technology for the identification of clinically relevant non-dematiaceous yeasts and related species

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

Induction of Protective Th1 Responses toCandida albicansby Antifungal Therapy Alone or in Combination with an Interleukin‐4 Antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2010.521522

10.3109/13693786.2010.521522

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference